Tick-borne encephalitis is a brain inflammation caused by the TBE virus that is transmitted through a tick bite. It can cause fever, vague nausea and a feeling of sickness for about a week, after which less than a third of affected people get the actual brain inflammation after a week without fever. Treatment of brain inflammation may require hospitalisation and may cause long-term neurological complications.
News
Monday 30.3.2020 klo 0:03
Wednesday 18.3.2020 klo 0:03
Vaccines are one of the greatest achievements in medicine. Anu Kantele, Professor of Infectious Diseases at MeVac, the Meilahti Vaccine Research Center of Helsinki University Hospital tells about vaccine development.
Thursday 13.2.2020 klo 0:02
According to information in the national vaccination register, almost all school-aged children are protected against chickenpox, but there is still room for improvement in the vaccinations of the youngest children. Almost one in five 1.5-year-olds had not been vaccinated over the years 2017-2019.
Chickenpox (also known as varicella) is highly contagious and without the vaccination almost everyone will get the disease. The most typical symptoms are blisters and fever lasting approximately 5 to 7 days.
Thursday 13.2.2020 klo 0:02
Finding out which vaccinations you need a couple of months before you travel is an important part of preparing for your trip. Every traveller should ensure that their vaccinations in the National Immunisation Programme are up to date. The need for other vaccinations depends on the age and state of health of the traveller as well as the destination, duration and nature of the trip. For example, the influenza vaccination is recommended for people in risk groups, and some countries require visitors to show a yellow fever vaccination certificate on arrival.
Thursday 21.11.2019 klo 15:11
The influenza epidemic has not yet begun in Finland, but some individual influenza A and B cases have been reported to the National Infectious Diseases Register.
Monday 16.9.2019 klo 16:09
HPV, or human papilloma virus, causes several cancers. It causes infections on the skin and the genitals, and some of the symptomless genital HPV infections develop into cancers of the cervix, vagina, vulva, penis and anus. HPV can also cause cancers in the head and neck area.
The HPV vaccine helps to prevent cervical cancer and its precancerous conditions. In addition, it can prevent some cancers of the vagina and vulva, of the head and neck area and the anus. The vaccination is most effective when it is given before the individual is sexually active.
Friday 26.7.2019 klo 16:07
Hepatitis, or liver infection, is the biggest killer after tuberculosis and nine times more prevalent than HIV. Hepatitis A and B are preventable with immunisation.
Wednesday 3.7.2019 klo 15:07
According to the National Infectious Diseases Register maintained by the National Institute for Health and Welfare (THL), 16 cases of measles were diagnosed in Finland in 2018. In the previous year, 11 cases were reported.
Tuesday 23.4.2019 klo 10:04
Ticks appear in the spring when the temperature permanently rises above zero. In Finland, ticks are found across the country, excluding the northernmost part of Lapland. Their numbers are highest in coastal areas and the archipelago. Click here to see a distribution map.
Thursday 28.3.2019 klo 9:03
A major study conducted in Denmark has affirmed that the MMR vaccine does not increase a child’s likelihood of becoming autistic.
Thursday 28.2.2019 klo 12:02
There are currently measles epidemics in many European countries where immunization coverage is not sufficiently high. Measles cases have also been observed this winter in Finland; these cases often arrive in Finland as souvenirs from foreign trips.
Tuesday 15.1.2019 klo 10:01
Influenza cases are steadily multiplying in Finland and are expected to exceed the epidemic threshold during January. The dominant virus types of the seasonal influenza outbreak in the rest of Europe and the USA are two influenza A viruses, and A(H1N1), a descendant of the swine flu, in particular has been widespread. The other subtype of the A virus, A(H3N2), has also been observed.
Thursday 13.12.2018 klo 10:12
This year the National Immunisation Programme will use a more comprehensive, quadrivalent influenza vaccine that protects against four types of virus. The Immunisation Programme includes an influenza vaccine administered as a nasal spray vaccine (children aged 2-6) and as an injectable vaccine, which both provide more comprehensive protection than last year’s vaccine.
Friday 28.9.2018 klo 11:09
The European Joint Action on Vaccination project to increase vaccination coverage among the European population was launched in September. Seventeen EU Member States, and Norway, Serbia, and Bosnia and Herzegovina are participating in the project. The Institute for Health and Welfare (THL) is involved in the project in Finland.
Monday 20.8.2018 klo 0:08
The National Institute for Health and Welfare (THL) has conducted a study of HPV vaccine administered to girls in the years 2013–2015. The study investigated whether the vaccine increases the risk of autoimmune disorders. There were approximately 241,000 subjects in all. Approximately half of them, or 56 percent, received the vaccine. HPV vaccine prevents HPV viral infection and the precursors of cervical cancer that it causes.
Thursday 28.6.2018 klo 0:06
For the first time, it has been shown that vaccines against human papillomavirus (HPV) prevent malignant HPV-associated cancers in women. This was the finding of a Finnish-Swedish research team coordinated by the University of Tampere. The finding was based on registry monitoring of Finnish subjects in randomised HPV-vaccinated and control cohorts.
Wednesday 30.5.2018 klo 0:05
The national vaccination register of Finland shows that influenza vaccination coverage of children below three years of age improved by three percentage points this season. Influenza vaccination coverage for people 65 years of age and older also increased slightly and is currently at 48 per cent.
Monday 16.4.2018 klo 0:04
The tetanus vaccination booster interval has been lengthened from 10 years to 20 years in adults of working age. Tetanus has become very rare in Finland and average anti-tetanus antibody levels in the Finnish population are high.
Wednesday 28.2.2018 klo 0:02
The national vaccination register’s vaccination coverage report shows that there has been a good vaccination coverage rate throughout Finland for children born in 2015. There are differences depending on the type of vaccine and the region, however.
Monday 29.1.2018 klo 0:01
According to a study of influenza vaccination conducted in Spain, it is advisable for the elderly to get vaccinated at least two times. Just two vaccinations may offer protection against serious illness requiring intensive care.